Whipple Disease Diagnosis and Management

Epidemiology

The worldwide prevalence of Whipple disease is approximately 30 affected individuals per million population 1

Whipple disease can present with a diverse array of clinical manifestations, including joint inflammation, gastrointestinal symptoms, weight loss, and neurological abnormalities, with arthralgia often being an early symptom that can precede other manifestations by years 1, 2
Gut stasis can lead to small intestinal bacterial overgrowth (SIBO), resulting in malabsorption and common deficiencies such as fat-soluble vitamins (A, D, E, K), vitamin B12, and iron (leading to iron deficiency anemia) 3, 4
Gut stasis results in abdominal distension, potential for large volume vomiting, and bacterial overgrowth 3

The gold standard for diagnosis of Whipple's disease is endoscopy with small intestinal biopsy, which shows characteristic macrophage infiltration and histological examination for foamy histiocytes 3, 2, 5
PCR testing can detect T. whipplei DNA in duodenal tissue samples, peripheral blood, and other affected tissues 2, 5
Specific testing for Whipple disease, such as small intestinal biopsy showing PAS-positive macrophage infiltration, PCR for Tropheryma whipplei, and histological examination showing foamy histiocytes containing PAS-positive inclusions, is necessary for diagnosis 2, 5
Diagnostic paracentesis is recommended to analyze ascitic fluid, including cell count and differential, total protein and albumin measurement, and calculation of serum-ascites albumin gradient (SAAG), by the American Association for the Study of Liver Diseases 6

Antimicrobial therapy is the cornerstone of treatment for Whipple disease, with initial therapy consisting of ceftriaxone or penicillin G intravenously for 2 weeks, followed by trimethoprim-sulfamethoxazole (TMP-SMX) orally for at least 1-2 years, as recommended by the European Association for the Study of the Liver and the American Gastroenterological Association 2, 7, 5
Nutritional support is often required to address malabsorption and weight loss, and regular follow-up is essential due to the risk of relapse
Management of ascites in Whipple disease may include sodium restriction, diuretic therapy based on SAAG values, and therapeutic paracentesis for large-volume ascites, with the goal of reducing ascites and improving patient outcomes 8

Ascites cases are primarily due to cirrhosis (approximately 85% in the United States), with other causes including heart failure, cancer, tuberculosis, nephrotic syndrome, and mixed causes 8, 9